Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Adherence to Adjuvant Anastrozole Therapy in Postmenopausal Patients With Early Breast Cancer Over One Year Follow-up.

NCT00737009 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00737009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00737009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Adherence to Adjuvant Anastrozole Therapy in Postmenopausal Patients With Early Breast Cancer Over One Year Follow-up.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 31, 2008
Completion date
March 31, 2011
Enrollment
259 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer